Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy-Reference-Cited by-同舟云学术

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

Published:2017-01 Issue:1 Volume:5 Page:1283105
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Codecasa Luigi R.¹,Toumi Mondher²,D’Ausilio Anna³,Aiello Andrea³,Damele Francesco⁴,Termini Roberta⁴,Uglietti Alessia⁴,Hettle Robert⁵,Graziano Giorgio⁶,De Lorenzo Saverio⁷

Affiliation:

1. Regional TB Reference Centre, Villa Marelli Institute/ASST Niguarda Ca’ Granda, Milano, Italy

2. Faculty of Medicine, Public Health Department, Aix-Marseille University, Marseille, France

3. Creativ-Ceutical, Milano, Italy

4. Janssen-Cilag, Cologno Monzese, Italy

5. Parexel International, London, UK

6. Post-graduate Residency School in Hygiene and Preventive Medicine, University of Palermo, Palermo, Italy

7. E. Morelli Hospital ASST, Reference Center for MDR-TB and HIV-TB, Sondalo, Italy

Publisher

Informa UK Limited

Link

https://tandfonline.com/doi/pdf/10.1080/20016689.2017.1283105

Reference22 articles.

1. MDR Tuberculosis — Critical Steps for Prevention and Control

2. XDR Tuberculosis — Implications for Global Public Health

3. Tuberculosis in migrants from 106 countries to Italy, 2008–2014

4. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation

5. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis;Journal of Clinical Laboratory Analysis;2024-08

2. A systematic review of economic evaluations of pharmacological treatments for active tuberculosis;Frontiers in Public Health;2024-04-16

3. The effectiveness of chemotherapy regimens with the inclusion of linezolid in children and teenagers with tuberculosis;Tuberculosis and socially significant diseases;2023-12-15

4. Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-07-19

5. Cost-Effectiveness Analysis of Combined Chemotherapy Regimen Containing Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis in China;BIOMED ENVIRON SCI;2023